BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 9872520)

  • 1. Preliminary study on a novel quadruple eradication therapy with a mucoprotective drug, sofalcone, for Helicobacter pylori infection.
    Sakaki N; Arakawa T; Kozawa H; Yamada Y; Kato H; Kamisawa T; Momma K
    J Clin Gastroenterol; 1998; 27 Suppl 1():S187-91. PubMed ID: 9872520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sofalcone, a mucoprotective agent, increases the cure rate of Helicobacter pylori infection when combined with rabeprazole, amoxicillin and clarithromycin.
    Isomoto H; Furusu H; Ohnita K; Wen CY; Inoue K; Kohno S
    World J Gastroenterol; 2005 Mar; 11(11):1629-33. PubMed ID: 15786539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of 1-week and 2-week triple therapy with omeprazole, amoxicillin, and clarithromycin in peptic ulcer patients with Helicobacter pylori infection: results of a randomized controlled trial.
    Kiyota K; Habu Y; Sugano Y; Inokuchi H; Mizuno S; Kimoto K; Kawai K
    J Gastroenterol; 1999; 34 Suppl 11():76-9. PubMed ID: 10616771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastric urease activity is inversely associated with the success of treatment for Helicobacter pylori: effect of sofalcone.
    Suzuki M; Kitahora T; Nagahashi S; Suzuki H; Mori M; Hibi T; Ishii H
    J Clin Gastroenterol; 1998; 27 Suppl 1():S183-6. PubMed ID: 9872519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A retrospective study on efficacy of proton-pump inhibitor-based triple therapy for eradication of Helicobacter pylori in patients with chronic renal failure.
    Mak SK; Loo CK; Wong PN; Lo KY; Tong GM; Lam EK; Wong AK
    Singapore Med J; 2003 Feb; 44(2):74-8. PubMed ID: 14503780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Twice-daily, 10-day triple therapy with omeprazole, amoxicillin, and clarithromycin for Helicobacter pylori eradication in duodenal ulcer disease: results of three multicenter, double-blind, United States trials.
    Laine L; Suchower L; Frantz J; Connors A; Neil G
    Am J Gastroenterol; 1998 Nov; 93(11):2106-12. PubMed ID: 9820381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Follow-up survey of a large-scale multicenter, double-blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients.
    Asaka M; Kato M; Sugiyama T; Satoh K; Kuwayama H; Fukuda Y; Fujioka T; Takemoto T; Kimura K; Shimoyama T; Shimizu K; Kobayashi S;
    J Gastroenterol; 2003; 38(4):339-47. PubMed ID: 12743773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significant increase in eradication rates of Helicobacter pylori infection with two consecutive dual therapies (omeprazole and amoxycillin or omeprazole and clarithromycin). A randomized study in 450 Spanish patients.
    Moreno JA; Pajares JM; Santander C; Carpintero P; Hermida C; Lara S; García Grávalos R
    J Gastroenterol; 1996 Nov; 31 Suppl 9():48-52. PubMed ID: 8959519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [new one-week triple therapies with metronidazole for the eradication of Helicobacter pylori: clarithromycin or amoxycillin as the second antibiotic].
    Gisbert JP; Boixeda D; Martín de Argila C; Redondo C; Moreno L; Abraira V; García Plaza A
    Med Clin (Barc); 1998 Jan; 110(1):1-5. PubMed ID: 9527978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triple therapy with omeprazole, amoxicillin and clarithromycin is effective against Helicobacter pylori infection in gastric ulcer patients as well as in duodenal ulcer patients. Results of a randomized controlled trial in Japan.
    Habu Y; Mizuno S; Hirano S; Kiyota K; Inokuchi H; Kimoto K; Nakajima M; Kawai K
    Digestion; 1998; 59(4):321-5. PubMed ID: 9693202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative effect of lansoprazole/amoxicillin with omeprazole/amoxicillin for the eradication of Helicobacter pylori in patients with duodenal ulcer].
    Kayser S; Flury R; Zbinden R; Fried M; Wirth HP
    Schweiz Med Wochenschr; 1997 Apr; 127(17):722-7. PubMed ID: 9221483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcome and influencing factors of a new short-term quadruple therapy for Helicobacter pylori eradication: a randomized controlled trial (MACLOR study).
    Treiber G; Wittig J; Ammon S; Walker S; van Doorn LJ; Klotz U
    Arch Intern Med; 2002 Jan; 162(2):153-60. PubMed ID: 11802748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effectiveness of omeprazole, clarithromycin and amoxycillin therapy to eradicate Helicobacter pylori in patients with active peptic ulcer. Preliminary results of GENPY study].
    Baños F; Madridejos R; Cabezas C; Burrull M; Lafuente C; Morera R
    Med Clin (Barc); 2000 Apr; 114(12):441-3. PubMed ID: 10846695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sofalcone].
    Fukuda Y; Shimoyama T
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():704-9. PubMed ID: 11979875
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of the efficacy and tolerability of four different therapeutic regimens for the Helicobacter pylori eradication.
    Tursi A; Cammarota G; Montalto M; Papa A; Cuoco L; Veneto GM; Cannizzaro O; Fedeli G; Gasbarrini G
    Panminerva Med; 1996 Sep; 38(3):145-9. PubMed ID: 9009677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment with omeprazole, clarithromycin and amoxicillin over 6 days in patients with Helicobacter pylori-infected duodenal ulcer].
    García-Romero E; del Val A; Garrigues V; Cuquerella J; Higón MD; Barrachina M; Pons V; Bixquert M; Ponce J
    Gastroenterol Hepatol; 1999 Jan; 22(1):1-6. PubMed ID: 10089703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the efficacy and safety of different formulations of omeprazole-based triple therapies in the treatment of Helicobacter pylori-positive peptic ulcer.
    Kim HS; Lee DK; Kim KH; Jeong YS; Kim JW; Seo JI; Baik SK; Kwon SO; Cho MY
    J Gastroenterol; 2001 Feb; 36(2):96-102. PubMed ID: 11227677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens.
    Schwartz H; Krause R; Sahba B; Haber M; Weissfeld A; Rose P; Siepman N; Freston J
    Am J Gastroenterol; 1998 Apr; 93(4):584-90. PubMed ID: 9576452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effectiveness of the eradication of Helicobacter pylori by treatment with omeprazol, amoxicillin, and clarithromycin according to dosage and administration schedule].
    Martín Mir ML; Val J; Fuentes J; García S; Yus C; Simón MA; Gomollón F
    Gastroenterol Hepatol; 1998 Nov; 21(9):432-6. PubMed ID: 9882932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of the use of rebamipide in the scheme of triple eradication therapy of Helicobacter pylori infection: a prospective randomized comparative study.
    Andreev DN; Maev IV; Dicheva DT; Samsonov AA; Partzvania-Vinogradova EV
    Ter Arkh; 2018 Aug; 90(8):27-32. PubMed ID: 30701936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.